Nucleophosmin (NPM1) is a nucleolar phosphoprotein that is mutated in 25–35% of patients with AML and is associated with good prognosis, including in patients of advanced age [14], [15], [16]. The gene discussed is NPM1; the disease is acute myeloid leukemia.